Indian drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday the U.S. Food and Drug Administration (FDA) had put a partial clinical hold on its application for an experimental dermatological drug due to the potential of thrombotic events.from Moneycontrol Business News https://ift.tt/zOykxBf
No comments:
Post a Comment